Chargement en cours...
How Four Health Plans Manage Biotech Drugs
With the number of market-approved biotech drugs approved by the U.S. Food and Drug Administration expected to jump soon, health plans are scrambling to redesign benefit structures, manage utilization, and get a handle on the costs of these new therapies. Here’s how four health plans are addressing...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioCommunications LLC
2004
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3555165/ https://ncbi.nlm.nih.gov/pubmed/23372496 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|